Ascelia Pharma AB
STO:ACE

Watchlist Manager
Ascelia Pharma AB Logo
Ascelia Pharma AB
STO:ACE
Watchlist
Price: 4.135 SEK 6.85% Market Closed
Market Cap: 479.8m SEK

Wall Street
Price Targets

ACE Price Targets Summary
Ascelia Pharma AB

Wall Street analysts forecast ACE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACE is 8.415 SEK with a low forecast of 6.565 SEK and a high forecast of 10.5 SEK.

Lowest
Price Target
6.565 SEK
59% Upside
Average
Price Target
8.415 SEK
104% Upside
Highest
Price Target
10.5 SEK
154% Upside
Ascelia Pharma AB Competitors:
Price Targets
IDYA
IDEAYA Biosciences Inc
168% Upside
2487
Cutia Therapeutics
48% Upside
STOK
Stoke Therapeutics Inc
142% Upside
LYTIX
Lytix Biopharma AS
70% Upside
ELUT
Elutia Inc
404% Upside
PEB
Pacific Edge Ltd
21% Downside
ALKS
Alkermes Plc
32% Upside

Revenue
Forecast

Revenue Estimate
Ascelia Pharma AB

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Ascelia Pharma AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

Net Income
Forecast

Net Income Estimate
Ascelia Pharma AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACE's stock price target?
Price Target
8.415 SEK

According to Wall Street analysts, the average 1-year price target for ACE is 8.415 SEK with a low forecast of 6.565 SEK and a high forecast of 10.5 SEK.

Back to Top